These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7764073)

  • 21. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
    Blaney SM; Daniel MJ; Harker AJ; Godwin K; Balis FM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2779-82. PubMed ID: 8593019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cells.
    Sommadossi JP; Schinazi RF; Chu CK; Xie MY
    Biochem Pharmacol; 1992 Nov; 44(10):1921-5. PubMed ID: 1333199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated high-performance liquid chromatographic analysis of (-)-2'-deoxy-3'-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems.
    Hsyu PH; Lloyd TL
    J Chromatogr B Biomed Appl; 1994 May; 655(2):253-9. PubMed ID: 8081471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine.
    Gao WY; Johns DG; Mitsuya H
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):371-7. PubMed ID: 10772721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.
    Schinazi RF; Boudinot FD; Ibrahim SS; Manning C; McClure HM; Liotta DC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2432-8. PubMed ID: 1336946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.
    Larder BA; Kemp SD; Harrigan PR
    Science; 1995 Aug; 269(5224):696-9. PubMed ID: 7542804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity.
    Cui L; Schinazi RF; Gosselin G; Imbach JL; Chu CK; Rando RF; Revankar GR; Sommadossi JP
    Biochem Pharmacol; 1996 Nov; 52(10):1577-84. PubMed ID: 8937473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral and cellular metabolism interactions between Dexelvucitabine and lamivudine.
    Hernandez-Santiago BI; Mathew JS; Rapp KL; Grier JP; Schinazi RF
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2130-5. PubMed ID: 17403996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and comparative evaluation of two antiviral agents: beta-L-Fd4C and beta-D-Fd4C.
    Chen SH; Lin S; King I; Spinka T; Dutschman GE; Gullen EA; Cheng YC; Doyle TW
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3245-50. PubMed ID: 9873711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP.
    Feng JY; Shi J; Schinazi RF; Anderson KS
    FASEB J; 1999 Sep; 13(12):1511-7. PubMed ID: 10463941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamivudine (3TC) phosphorylation and drug interactions in vitro.
    Kewn S; Veal GJ; Hoggard PG; Barry MG; Back DJ
    Biochem Pharmacol; 1997 Sep; 54(5):589-95. PubMed ID: 9337075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.
    Charvet AS; Camplo M; Faury P; Graciet JC; Mourier N; Chermann JC; Kraus JL
    J Med Chem; 1994 Jul; 37(14):2216-23. PubMed ID: 8035429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.
    Balzarini J; Pelemans H; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 May; 49(5):882-90. PubMed ID: 8622638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate specificity of Escherichia coli thymidine phosphorylase for pyrimidine nucleosides with anti-human immunodeficiency virus activity.
    Schinazi RF; Peck A; Sommadossi JP
    Biochem Pharmacol; 1992 Jul; 44(2):199-204. PubMed ID: 1322661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.
    Ingrand D; Weber J; Boucher CA; Loveday C; Robert C; Hill A; Cammack N
    AIDS; 1995 Dec; 9(12):1323-9. PubMed ID: 8605051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of lamivudine (3TC) by competitive immunoassay.
    Akeb F; Creminon C; Nevers MC; Grassi J; Duval D; Guedj R
    Nucleosides Nucleotides; 1999; 18(4-5):893-6. PubMed ID: 10432705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group.
    Lewis LL; Venzon D; Church J; Farley M; Wheeler S; Keller A; Rubin M; Yuen G; Mueller B; Sloas M; Wood L; Balis F; Shearer GM; Brouwers P; Goldsmith J; Pizzo PA
    J Infect Dis; 1996 Jul; 174(1):16-25. PubMed ID: 8655986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.